ALGN Stock Recent News
ALGN LATEST HEADLINES
HONG KONG--(BUSINESS WIRE)--Align Technology, Inc. (“Align”) (Nasdaq: ALGN), a leading global medical device company that designs, manufactures, and sells the Invisalign® System of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for digital orthodontics and restorative dentistry, today announced that Align's Invisalign Palatal Expander System is now commercially available in Hong Kong for broad patient applicability, including growing children, teens and adults (with sur.
SINGAPORE--(BUSINESS WIRE)--Align Technology, Inc. (“Align”) (Nasdaq: ALGN) a leading global medical device company that designs, manufactures, and sells the Invisalign® System of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for digital orthodontics and restorative dentistry, today announced that Align's Invisalign Palatal Expander System has been listed on the Singapore Medical Device Register as a class B medical device. It is now commercially available in Singapore.
TEMPE, Ariz.--(BUSINESS WIRE)--Align Technology, Inc. (Nasdaq: ALGN) a leading global medical device company that designs, manufactures, and sells the Invisalign® System of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for digital orthodontics and restorative dentistry, today announced that it will report third quarter 2024 financial results on Wednesday, October 23, 2024, after the close of market. Financial results will be released at 4:00 p.m. ET (1:00 p.m. PT) and.
TEMPE, Ariz.--(BUSINESS WIRE)--Align Technology, Inc. (“Align”) (Nasdaq: ALGN) a leading global medical device company that designs, manufactures, and sells the Invisalign® System of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for digital orthodontics and restorative dentistry, today announced that the U.S. District Court for the Northern District of California has granted preliminary approval of a settlement to resolve shareholder derivative litigation that has been.
ALGN is facing a decline in Invisalign ASPs for comprehensive treatment options. This is resulting in a decline in the company's revenues.
TEMPE, Ariz.--(BUSINESS WIRE)--Align Technology, Inc. (Nasdaq: ALGN), a leading global medical device company that designs, manufactures, and sells the Invisalign® System of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for digital orthodontics and restorative dentistry, today announced leadership updates for the Asia Pacific, Americas, and EMEA regions. Medical technology industry executive David Carr has joined Align as EVP and MD of the Asia Pacific region. Raj Pudi.
Align Technology , the maker of Invisalign clear teeth aligners, agreed to pay $27.5 million to settle a lawsuit claiming it entered an illegal antitrust conspiracy that drove up prices of aligners made by rival SmileDirectClub.
Align Technology (ALGN) reported earnings 30 days ago. What's next for the stock?
Dublin, Aug. 22, 2024 (GLOBE NEWSWIRE) -- The "Columbia Digital Dentistry Market Size, Share & Trends Analysis | 2024-2030 | MedSuite | Includes: Dental CAD/CAM Devices, Dental CAD/CAM Materials (Discs & Blocks), Dental 3D Printers, and 2 more" report has been added to ResearchAndMarkets.com's offering. In 2023, the Colombian digital dentistry market was valued at nearly $14.3 million. It is expected to grow at a CAGR of 3.8%, reaching over $18.6 million by the end of the forecast period. The comprehensive report on the Colombian market for digital dentistry covers various segments, including computer-aided design/computer-aided manufacturing (CAD/CAM) devices, CAD/CAM materials, dental 3D printers, dental 3D printer materials, and CAD/CAM software. Currently, the majority of Colombia's digital dentistry market share is controlled by Dentsply Sirona, Ivoclar Vivadent, and 3D Systems.
Align's recent earnings were underwhelming, leading to a 21.56% YTD stock drop. Q2 2024 earnings showed mixed results, with EPS beating estimates but revenue slightly lower than expected. Align's potential lies in its large TAM, strong gross margin, and top management, but growth needs to accelerate for investor trust.